Amarin | AMRN - Índice Preço/Lucro





Pe Alterar Data
AbbVie 24.03 86.23 2025-12
Alnylam Pharmaceuticals 170.7 367.33 2025-12
Amarin 91.05 88.3 2023-06
AstraZeneca 27.29 5.8 2025-12
Esperion Therapeutics 129.79 129 2024-12
GlaxoSmithKline 11.15 0.29 2025-12
Halozyme Therapeutics 23.16 7.7 2025-12
Ionis Pharmaceuticals 396.15 79.28 2022-09
Neurocrine Biosciences 835.47 802.2 2025-12
Novartis 15.74 0.15 2025-09